AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 32%
#1657 out of 5177 analysts
Average Return
+17.35%
Win Rate
83%10 out of 12
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Theravance Biopharma IncTBPH | +88.77% | $10.60 | $20.01 | 2025-06-16 - 2026-01-16 | Strong Buy |
Sionna Therapeutics IncSION | +80.90% | $21.62 | $39.11 | 2025-09-07 - 2026-01-16 | Strong Buy |
Contineum Therapeutics IncCTNM | +64.43% | $7.14 | $11.74 | 2025-03-12 - 2026-01-16 | Strong Buy |
Sagimet Biosciences IncSGMT | +32.90% | $4.62 | $6.14 | 2025-01-26 - 2026-01-16 | Strong Buy |
Kalvista Pharmaceuticals IncKALV | +20.96% | $12.07 | $14.60 | 2025-03-25 - 2026-01-16 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Armata Pharmaceuticals IncARMP | 1 | Strong Buy | $15.00 | +134.38% | Initiates Coverage On | 12 days ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $64.00 | +92.54% | Upgrades | 2 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $46.00 | +17.62% | Initiates Coverage On | 4 months ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | +19.94% | Initiates Coverage On | 7 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | +339.74% | Maintains | 7 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +753.39% | Initiates Coverage On | 9 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | +105.48% | Maintains | 10 months ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | +95.91% | Initiates Coverage On | 10 months ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.